SlideShare ist ein Scribd-Unternehmen logo
1 von 20
[object Object]
 The major causes of inter subject pharmacokinetic  variability are  :- 	,[object Object]
Age          1.Drug metabolism in new born        2.Plasma protein bonding in new born        3.Renal excretion in new born        4.Drug metabolism in children ,[object Object]
Disease,[object Object]
[object Object]
Drug binding, metabolism, and excretion may change as a function of age.
The study panel was divided into 5 groups:                        		              Newborns (2 to 3 days) 	          Infants (1 to 12 months)               Children (4 to 9 years)                Adults (16 to 37 years)                Elderly subjects (more than 70 years)
[object Object]
Clearance increased from 0.9 to 2.5 ml/min. when comparing patient 1 to 8 days old with patient 9 to 30  days old.
The mean clearance of ceftriaxone in children ranging in age from 1 to 12 months and from 1 to 6 years was 6.2 ml/min. and 9.1 ml/min. respectively.
The  18 to 49 years old age group had the highest clearance of ceftriaxone, 17 ml/min. ,[object Object]
Very elderly patients 75 to 92 years of age had an average clearance of about 8 ml/min.,[object Object]
Most of the enzymatic microsomal systems required for drug metabolism are present at birth, but their  concentration are usually lower than adult levels.
In  general drugs subject to  biotransformation are eliminated more slowly in newborn than in adult.,[object Object]
Sulfate conjugation seems to be as efficient in newborns as in adults, but conjugation with glucuronic acid is considerably reduced, reaching adult level only after 3 years of age.
This deficiency is responsible for the serious adverse effects observed in newborn after administration of chloramphenicol a drug that is ordinarily conjugated with glucuroni acid.  ,[object Object]
The amount of unchanged theophylline in urine in premature infants decreases with postnatal age, whereas the excretion of metabolites increases with age. ,[object Object]
In each case binding in plasma protein is level in the newborns than in the adults.
Increase in plasma protein binding is an increase in apparent volume of distribution in the newborn.

Weitere ähnliche Inhalte

Was ist angesagt?

Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its application
pavithra vinayak
 

Was ist angesagt? (20)

Birth defect due to drugs
Birth defect due to drugsBirth defect due to drugs
Birth defect due to drugs
 
Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing interval
 
Pharmacokinetic and pharmacodynamic correlation
Pharmacokinetic and pharmacodynamic correlationPharmacokinetic and pharmacodynamic correlation
Pharmacokinetic and pharmacodynamic correlation
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens
 
NOMOGRAMS AND TABULATIONS IN DESIGNING DOSAGE REGIMEN.pptx
NOMOGRAMS AND TABULATIONS IN   DESIGNING DOSAGE REGIMEN.pptxNOMOGRAMS AND TABULATIONS IN   DESIGNING DOSAGE REGIMEN.pptx
NOMOGRAMS AND TABULATIONS IN DESIGNING DOSAGE REGIMEN.pptx
 
6. dosing in obese patient
6. dosing in obese patient6. dosing in obese patient
6. dosing in obese patient
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedback
 
Dose adjustment in renal disease
Dose adjustment in renal diseaseDose adjustment in renal disease
Dose adjustment in renal disease
 
Effects of Liver disease on Pharmacokinetics
Effects of Liver disease on Pharmacokinetics Effects of Liver disease on Pharmacokinetics
Effects of Liver disease on Pharmacokinetics
 
Individualization of drug dosage regimen
Individualization of drug dosage regimenIndividualization of drug dosage regimen
Individualization of drug dosage regimen
 
digoxin Therapeutic drug monitoring
digoxin Therapeutic drug monitoring digoxin Therapeutic drug monitoring
digoxin Therapeutic drug monitoring
 
Dosing in childrens
Dosing in childrensDosing in childrens
Dosing in childrens
 
Dose adjustment in Renal failure
Dose adjustment in Renal failure Dose adjustment in Renal failure
Dose adjustment in Renal failure
 
Population pharmacokinetics
Population pharmacokineticsPopulation pharmacokinetics
Population pharmacokinetics
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its application
 
Individualization of dosage regimen
Individualization of dosage regimenIndividualization of dosage regimen
Individualization of dosage regimen
 
TDM OF DRUGS USED IN CARDIOVASCULAR DISEASES
TDM OF DRUGS USED IN CARDIOVASCULAR DISEASESTDM OF DRUGS USED IN CARDIOVASCULAR DISEASES
TDM OF DRUGS USED IN CARDIOVASCULAR DISEASES
 
Non compartmental pharmacokinetics & physiologic pharmacokinetic models by akt
Non compartmental pharmacokinetics & physiologic pharmacokinetic models by aktNon compartmental pharmacokinetics & physiologic pharmacokinetic models by akt
Non compartmental pharmacokinetics & physiologic pharmacokinetic models by akt
 
Population pharmacokinetics
Population pharmacokineticsPopulation pharmacokinetics
Population pharmacokinetics
 

Andere mochten auch

Applications of pharmacokinetics parameters in disease states
Applications of pharmacokinetics parameters in disease statesApplications of pharmacokinetics parameters in disease states
Applications of pharmacokinetics parameters in disease states
Umair hanif
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug Monitoring
Tulasi Raman
 
35 effects of renal disease on pharmacokinetics
35 effects of renal disease on pharmacokinetics35 effects of renal disease on pharmacokinetics
35 effects of renal disease on pharmacokinetics
Dang Thanh Tuan
 
Clinical pharmacology in special populations 2014
Clinical pharmacology in special populations 2014Clinical pharmacology in special populations 2014
Clinical pharmacology in special populations 2014
vanessawhitehawk
 

Andere mochten auch (20)

Applications of pharmacokinetics parameters in disease states
Applications of pharmacokinetics parameters in disease statesApplications of pharmacokinetics parameters in disease states
Applications of pharmacokinetics parameters in disease states
 
Introduction to dosage regimen and Individualization of dosage regimen
Introduction to dosage regimen and Individualization of dosage regimenIntroduction to dosage regimen and Individualization of dosage regimen
Introduction to dosage regimen and Individualization of dosage regimen
 
Obsity
ObsityObsity
Obsity
 
Factors affecting pharmacokinetic parameters
Factors affecting pharmacokinetic parametersFactors affecting pharmacokinetic parameters
Factors affecting pharmacokinetic parameters
 
Dosage Regimen
Dosage RegimenDosage Regimen
Dosage Regimen
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 
Dosage regimen
Dosage regimenDosage regimen
Dosage regimen
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug Monitoring
 
Trouble Shooting of Chemical Process Industry
Trouble Shooting of Chemical Process IndustryTrouble Shooting of Chemical Process Industry
Trouble Shooting of Chemical Process Industry
 
Pharmacokinetic changes of drugs in hepatic diseases
Pharmacokinetic changes of drugs in hepatic diseasesPharmacokinetic changes of drugs in hepatic diseases
Pharmacokinetic changes of drugs in hepatic diseases
 
Renal Clearance
Renal ClearanceRenal Clearance
Renal Clearance
 
Pharmacokinetics In Special Populations
Pharmacokinetics In Special PopulationsPharmacokinetics In Special Populations
Pharmacokinetics In Special Populations
 
Pharmacokinetics (updated 2011) - drdhriiti
Pharmacokinetics (updated 2011)  - drdhriitiPharmacokinetics (updated 2011)  - drdhriiti
Pharmacokinetics (updated 2011) - drdhriiti
 
35 effects of renal disease on pharmacokinetics
35 effects of renal disease on pharmacokinetics35 effects of renal disease on pharmacokinetics
35 effects of renal disease on pharmacokinetics
 
Design and optimizing of dosage regimen - pharmacology
Design and optimizing of dosage regimen - pharmacology Design and optimizing of dosage regimen - pharmacology
Design and optimizing of dosage regimen - pharmacology
 
Renal clearance
Renal clearanceRenal clearance
Renal clearance
 
Pilot plant scale up techniques used in pharmaceutical manufacturing
Pilot plant scale up techniques used in pharmaceutical manufacturingPilot plant scale up techniques used in pharmaceutical manufacturing
Pilot plant scale up techniques used in pharmaceutical manufacturing
 
excretion
excretionexcretion
excretion
 
PK and Drug Therapy in pediatrics, geriatrics and pregnancy & Lactation
PK and Drug Therapy in pediatrics, geriatrics and pregnancy & LactationPK and Drug Therapy in pediatrics, geriatrics and pregnancy & Lactation
PK and Drug Therapy in pediatrics, geriatrics and pregnancy & Lactation
 
Clinical pharmacology in special populations 2014
Clinical pharmacology in special populations 2014Clinical pharmacology in special populations 2014
Clinical pharmacology in special populations 2014
 

Ähnlich wie Pharmacokinetic variability

Drugs used in special age groups like children, elderly and preganancy
Drugs used in special age groups like children, elderly and preganancyDrugs used in special age groups like children, elderly and preganancy
Drugs used in special age groups like children, elderly and preganancy
Roopali Somani
 
Drug therapy-Neonates and pediatrics
Drug therapy-Neonates and pediatricsDrug therapy-Neonates and pediatrics
Drug therapy-Neonates and pediatrics
Tsegaye Melaku
 
Pharmacology for pediatric anaesthesia [autosaved]
Pharmacology for pediatric anaesthesia [autosaved]Pharmacology for pediatric anaesthesia [autosaved]
Pharmacology for pediatric anaesthesia [autosaved]
DeepakGupta825
 
Clinical trial in special population final
Clinical trial in special population finalClinical trial in special population final
Clinical trial in special population final
anupam raghunath
 

Ähnlich wie Pharmacokinetic variability (20)

Clinical Pharmacokinetics
Clinical PharmacokineticsClinical Pharmacokinetics
Clinical Pharmacokinetics
 
Paediatric pharmaco-kinetics
Paediatric pharmaco-kinetics Paediatric pharmaco-kinetics
Paediatric pharmaco-kinetics
 
Drug therapy in children
Drug therapy in childrenDrug therapy in children
Drug therapy in children
 
Analgesic in Pedo-Part 1.pptx
Analgesic in Pedo-Part 1.pptxAnalgesic in Pedo-Part 1.pptx
Analgesic in Pedo-Part 1.pptx
 
Drug distribution in pediatrics
Drug distribution in pediatricsDrug distribution in pediatrics
Drug distribution in pediatrics
 
Pediatric drug for clinical pharmacy student 1
Pediatric drug for clinical pharmacy student 1Pediatric drug for clinical pharmacy student 1
Pediatric drug for clinical pharmacy student 1
 
Neonatal pediatric-pharmacology
Neonatal pediatric-pharmacologyNeonatal pediatric-pharmacology
Neonatal pediatric-pharmacology
 
Drugs used in special age groups like children, elderly and preganancy
Drugs used in special age groups like children, elderly and preganancyDrugs used in special age groups like children, elderly and preganancy
Drugs used in special age groups like children, elderly and preganancy
 
Individualization of drug
Individualization of drugIndividualization of drug
Individualization of drug
 
Drug therapy-Neonates and pediatrics
Drug therapy-Neonates and pediatricsDrug therapy-Neonates and pediatrics
Drug therapy-Neonates and pediatrics
 
Paediatrics
PaediatricsPaediatrics
Paediatrics
 
Pediatric pharmacotherapy
Pediatric pharmacotherapyPediatric pharmacotherapy
Pediatric pharmacotherapy
 
prescribing in paediatrics.pptx
prescribing in paediatrics.pptxprescribing in paediatrics.pptx
prescribing in paediatrics.pptx
 
Drug use in paediatric & geriatric patients
Drug use in paediatric & geriatric patientsDrug use in paediatric & geriatric patients
Drug use in paediatric & geriatric patients
 
Clinical pharmacy age factors : Features of the Rational use of Medicines
Clinical pharmacy age factors : Features of the Rational use of MedicinesClinical pharmacy age factors : Features of the Rational use of Medicines
Clinical pharmacy age factors : Features of the Rational use of Medicines
 
Pharmacology for pediatric anaesthesia [autosaved]
Pharmacology for pediatric anaesthesia [autosaved]Pharmacology for pediatric anaesthesia [autosaved]
Pharmacology for pediatric anaesthesia [autosaved]
 
Paediatric Pharmacology Part-2.pptx
Paediatric Pharmacology Part-2.pptxPaediatric Pharmacology Part-2.pptx
Paediatric Pharmacology Part-2.pptx
 
Clinical trial in special population final
Clinical trial in special population finalClinical trial in special population final
Clinical trial in special population final
 
paeds drug drug calculation and formulas
paeds drug drug calculation and formulaspaeds drug drug calculation and formulas
paeds drug drug calculation and formulas
 
Principles of pharmacotherapy in neonates and paediatric population21
Principles of pharmacotherapy in neonates and paediatric population21Principles of pharmacotherapy in neonates and paediatric population21
Principles of pharmacotherapy in neonates and paediatric population21
 

Kürzlich hochgeladen

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 

Kürzlich hochgeladen (20)

Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Plant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxPlant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptx
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 

Pharmacokinetic variability

  • 1.
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7. Drug binding, metabolism, and excretion may change as a function of age.
  • 8. The study panel was divided into 5 groups: Newborns (2 to 3 days) Infants (1 to 12 months) Children (4 to 9 years) Adults (16 to 37 years) Elderly subjects (more than 70 years)
  • 9.
  • 10. Clearance increased from 0.9 to 2.5 ml/min. when comparing patient 1 to 8 days old with patient 9 to 30 days old.
  • 11. The mean clearance of ceftriaxone in children ranging in age from 1 to 12 months and from 1 to 6 years was 6.2 ml/min. and 9.1 ml/min. respectively.
  • 12.
  • 13.
  • 14. Most of the enzymatic microsomal systems required for drug metabolism are present at birth, but their concentration are usually lower than adult levels.
  • 15.
  • 16. Sulfate conjugation seems to be as efficient in newborns as in adults, but conjugation with glucuronic acid is considerably reduced, reaching adult level only after 3 years of age.
  • 17.
  • 18.
  • 19. In each case binding in plasma protein is level in the newborns than in the adults.
  • 20. Increase in plasma protein binding is an increase in apparent volume of distribution in the newborn.
  • 21.
  • 22.
  • 23. The difference process of renal excretion on mature at different rates,
  • 24. Average glomerular filtration rate is 38.5 ml/min.
  • 25.
  • 26.
  • 27. Older infants age (6 months to 12 years) has higher drug metabolism capacity rates compared to adults. for example, clindamycin theophylline valproic acid Has faster elimination rate.
  • 28.
  • 29. Formula used to determine dosage form
  • 30. Child dose= SA of child(m²) ------------------------------
  • 31.
  • 32. The increase in gastric ph, the decrease in gastric emptying rate and the slower motility associated with pregnancy can affect the rate and extent of drug absorption.
  • 33.